MIBG scoring as a prognostic indicator in patients with stage IV neuroblastoma: A COG study.

G. Yanik,Marguerite T. Parisi,Arlene Naranjo,Katherine K. Matthay,Wendy B. London,Patrick McGrady,Susan G. Kreissman,Barry L. Shulkin

MIBG scoring as a prognostic indicator in patients with stage IV neuroblastoma: A COG study.

2010

G. Yanik
Marguerite T. Parisi
Arlene Naranjo
Katherine K. Matthay
Wendy B. London
Patrick McGrady
Susan G. Kreissman
Barry L. Shulkin

9516 Background: Over the past 2 decades, radiolabeled metaiodobenzylguanidine (mIBG) has proven to be a highly sensitive and specific marker for the detection of primary and metastatic neuroblasto...

Keywords:

Neuroblastoma
Cog
Pathology
Medicine
highly sensitive
stage iv
in patient
Internal medicine
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations